| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gordon Guyatt | Q5585214 |
| Victor Montori | Q7926167 | ||
| Edward J. Mills | Q89591828 | ||
| Keith Gallicano | Q125193108 | ||
| P2093 | author name string | Ping Wu | |
| Mike Clarke | |||
| P2860 | cites work | Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females | Q24679237 |
| Effects of St. John's wort on irinotecan metabolism | Q33184162 | ||
| Use and expenditure on complementary medicine in England: a population based survey | Q33939422 | ||
| St John's wort (Hypericum perforatum): drug interactions and clinical outcomes | Q34976869 | ||
| The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum). | Q34979382 | ||
| St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist | Q35165515 | ||
| Interaction of St John's wort with low‐dose oral contraceptive therapy: a randomized controlled trial | Q35825530 | ||
| Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects | Q35826093 | ||
| Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients | Q35846658 | ||
| St. John's wort: effect on CYP2D6 activity using dextromethorphan-dextrorphan ratios | Q43761157 | ||
| The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity | Q43775254 | ||
| Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin | Q43830741 | ||
| Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ). | Q43859427 | ||
| Effect of St John's wort on the pharmacokinetics of fexofenadine | Q44043537 | ||
| Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects | Q44289523 | ||
| Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients | Q44362349 | ||
| Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme | Q44586531 | ||
| Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations | Q44594349 | ||
| The interaction between St John's wort and an oral contraceptive | Q44685310 | ||
| Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers | Q44697441 | ||
| Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers | Q44697443 | ||
| St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole | Q44787217 | ||
| Indinavir concentrations and St John's wort. | Q55033637 | ||
| Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) | Q73145709 | ||
| St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 | Q73443725 | ||
| Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers | Q73443729 | ||
| Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers | Q73501072 | ||
| P433 | issue | 7456 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 27-30 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Interaction of St John's wort with conventional drugs: systematic review of clinical trials | |
| P478 | volume | 329 |
| Q42386638 | Adverse drug reactions as cause of admission to hospital: alcohol and other non-prescribed drugs may have impact on adverse drug reactions |
| Q26752468 | Clinically and pharmacologically relevant interactions of antidiabetic drugs |
| Q40104285 | Complementary medicine and general practice in an urban setting: a decade on. |
| Q92430456 | Complementary therapies for clinical depression: an overview of systematic reviews |
| Q99719959 | Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models |
| Q24651117 | Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide |
| Q36048039 | Effects of treatment with a commercially available St John's Wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin |
| Q34142678 | Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials |
| Q34238039 | Evaluation of metabolism-mediated herb-drug interactions |
| Q37787487 | Evidence-Based Management of Herb-Drug Interaction in Cancer Chemotherapy |
| Q92631863 | Extended Intake of Mulberry Leaf Extract Delayed Metformin Elimination via Inhibiting the Organic Cation Transporter 2 |
| Q34494412 | Hyperforin in St. John's wort drug interactions |
| Q47330864 | Influence of Shenxiong Glucose Injection on the Activities of Six CYP Isozymes and Metabolism of Warfarin in Rats Assessed Using Probe Cocktail and Pharmacokinetic Approaches |
| Q49804065 | Inhibitory Influence of Panax notoginseng Saponins on Aspirin Hydrolysis in Human Intestinal Caco-2 Cells. |
| Q51465582 | Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. |
| Q38645509 | Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications |
| Q33498604 | Interactions between herbal medicines and prescribed drugs: an updated systematic review |
| Q31122008 | New developments in hypericum extracts: data on efficacy and interactions |
| Q36842490 | Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects |
| Q42775755 | Pharmacokinetic drug interactions by herbal drugs: Critical evaluation and clinical relevance |
| Q37163340 | Potential of pharmacokinetic profiling for detecting herbal interactions with drugs |
| Q55222898 | Prevalence and Predictors of Herbal Medicine Use Among Adults in the United States. |
| Q36372525 | Review article: complementary and alternative therapies for inflammatory bowel disease |
| Q36096792 | St. John's Wort Attenuates Colorectal Carcinogenesis in Mice through Suppression of Inflammatory Signaling |
| Q46991286 | St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays. |
| Q89839532 | The Effects of Cruciferous Vegetable-Enriched Diets on Drug Metabolism: A Systematic Review and Meta-Analysis of Dietary Intervention Trials in Humans |
| Q35827865 | The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials |
| Q36729151 | The recovery time-course of CYP3A after induction by St John's wort administration |
| Q33630966 | Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression. |
| Q37217878 | Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries |
| Q33886054 | Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors. |
Search more.